Related Experiment Video
Updated: Mar 17, 2026

10:26
Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
Published on: March 12, 2018
8.5K
Copper-induced structural conversion templates prion protein oligomerization and neurotoxicity.
Chi-Fu Yen1, Dilshan S Harischandra2, Anumantha Kanthasamy2
1Department of Electrical and Computer Engineering, Iowa State University, Ames, IA 50011, USA.
Science Advances
|July 16, 2016
Summary
Copper exposure triggers prion protein (PrP) misfolding, leading to toxic aggregates. This molecular mechanism explains how copper causes neurodegeneration in prion disease.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Prion protein (PrP) misfolding and aggregation are central to prion diseases.
- The role of copper (Cu2+) in prion pathogenesis remains mechanistically unclear.
Purpose of the Study:
- To elucidate the molecular mechanism of Cu(2+)-induced PrP misfolding.
- To investigate the role of misfolded PrP in aggregate formation and neurotoxicity.
Main Methods:
- Single-molecule fluorescence assays to monitor PrP structural changes.
- Single-molecule force spectroscopy to quantify binding affinities.
- Real-time quaking-induced conversion (RT-QuIC) for seeding activity.
- Organotypic slice cultures for assessing neurotoxicity.
Main Results:
- Cu(2+) induces PrP monomers to misfold via the disordered amino-terminal region.
- Misfolded PrP monomers exhibit significantly higher binding affinity, promoting oligomerization.
- Misfolded PrP acts as a seed for templated amyloid formation.
- Misfolded PrP mediates inflammation and neuronal degeneration in brain tissue.
Conclusions:
- Establishes a direct molecular link between copper exposure and PrP neurotoxicity.
- Demonstrates that Cu(2+)-induced misfolding is a critical early step in prion pathogenesis.
- Highlights the seeding potential of misfolded PrP in driving aggregate formation and subsequent neurodegeneration.
Related Concept Videos
Amyloid Fibrils
12.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.8K
Amyloid Fibrils
6.9K
6.9K

